![]()
|
|
||||||||
J. Biol. Chem., Vol. 269, Issue 1, 86-93, Jan, 1994
JP Brakenhoff, FD de Hon, V Fontaine, E ten Boekel, H Schooltink, S Rose-John, PC Heinrich, J Content and LA Aarden
Neutralizing monoclonal antibodies specific for human interleukin-6 (IL- 6)
bind two distinct sites on the IL-6 protein (sites I and II). Their
interference with IL-6 receptor binding suggested that site I is a
receptor-binding site of IL-6, whereas site II is important for signal
transduction. Mutagenesis of site II could therefore result in the
isolation of IL-6 receptor antagonists. To test this hypothesis, a panel of
IL-6 mutant proteins was constructed that did not bind to a site
II-specific monoclonal antibody. One such site II mutant protein (with
double substitution of Gln-160 with Glu and Thr-163 with Pro) was found to
be an antagonist of human IL-6. It was inactive on human CESS cells, weakly
active on human HepG2 cells, but active on mouse B9 cells. It could
specifically antagonize the activity of wild-type IL-6 on CESS and HepG2
cells. The binding affinity of this variant for the 80-kDa IL-6 receptor
was similar to that of wild-type IL-6. High affinity binding to CESS cells,
however, was abolished, suggesting that the mutant protein is inactive
because the complex of the 80-kDa IL-6 receptor and the mutant protein
cannot associate with the signal transducer gp130. The human IL-6
antagonist protein may be potentially useful as a therapeutic agent.
Development of a human interleukin-6 receptor antagonist
Department of Autoimmune Diseases, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
F. Peelman, K. Van Beneden, L. Zabeau, H. Iserentant, P. Ulrichts, D. Defeau, A. Verhee, D. Catteeuw, D. Elewaut, and J. Tavernier Mapping of the Leptin Binding Sites and Design of a Leptin Antagonist J. Biol. Chem., September 24, 2004; 279(39): 41038 - 41046. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Fairlie, A. D. Uboldi, J. E. McCoubrie, C. C. Wang, E. F. Lee, S. Yao, D. P. De Souza, S. Mifsud, D. Metcalf, N. A. Nicola, et al. Affinity Maturation of Leukemia Inhibitory Factor and Conversion to Potent Antagonists of Signaling J. Biol. Chem., January 16, 2004; 279(3): 2125 - 2134. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, H. Wang, and J. Nicholas Detection of Direct Binding of Human Herpesvirus 8-Encoded Interleukin-6 (vIL-6) to both gp130 and IL-6 Receptor (IL-6R) and Identification of Amino Acid Residues of vIL-6 Important for IL-6R-Dependent and -Independent Signaling J. Virol., April 1, 2001; 75(7): 3325 - 3334. [Abstract] [Full Text] |
||||
![]() |
D.-c. Chow, X.-l. He, A. L. Snow, S. Rose-John, and K. C. Garcia Structure of an Extracellular gp130 Cytokine Receptor Signaling Complex Science, March 16, 2001; 291(5511): 2150 - 2155. [Abstract] [Full Text] |
||||
![]() |
L. Alexander, L. Denekamp, A. Knapp, M. R. Auerbach, B. Damania, and R. C. Desrosiers The Primary Sequence of Rhesus Monkey Rhadinovirus Isolate 26-95: Sequence Similarities to Kaposi's Sarcoma-Associated Herpesvirus and Rhesus Monkey Rhadinovirus Isolate 17577 J. Virol., April 1, 2000; 74(7): 3388 - 3398. [Abstract] [Full Text] |
||||
![]() |
X. Wan, H. Wang, and J. Nicholas Human Herpesvirus 8 Interleukin-6 (vIL-6) Signals through gp130 but Has Structural and Receptor-Binding Properties Distinct from Those of Human IL-6 J. Virol., October 1, 1999; 73(10): 8268 - 8278. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. R. Kaleeba, E. P. Bergquam, and S. W. Wong A Rhesus Macaque Rhadinovirus Related to Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 Encodes a Functional Homologue of Interleukin-6 J. Virol., July 1, 1999; 73(7): 6177 - 6181. [Abstract] [Full Text] |
||||
![]() |
J. E. Layton, G. Shimamoto, T. Osslund, A. Hammacher, D. K. Smith, H. R. Treutlein, and T. Boone Interaction of Granulocyte Colony-stimulating Factor (G-CSF) with Its Receptor. EVIDENCE THAT Glu19 of G-CSF INTERACTS WITH Arg288 OF THE RECEPTOR J. Biol. Chem., June 18, 1999; 274(25): 17445 - 17451. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Frohm Nilsson, B. Sandstedt, O. Sorensen, G. Weber, N. Borregaard, and M. Stahle-Backdahl The Human Cationic Antimicrobial Protein (hCAP18), a Peptide Antibiotic, Is Widely Expressed in Human Squamous Epithelia and Colocalizes with Interleukin-6 Infect. Immun., May 1, 1999; 67(5): 2561 - 2566. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Gadient and P. H. Patterson Leukemia Inhibitory Factor, Interleukin 6, and Other Cytokines Using the GP130 Transducing Receptor: Roles in Inflammation and Injury Stem Cells, May 1, 1999; 17(3): 127 - 137. [Abstract] [Full Text] |
||||
![]() |
C. Renne, K.-J. Kallen, J. Mullberg, T. Jostock, J. Grotzinger, and S. Rose-John A New Type of Cytokine Receptor Antagonist Directly Targeting gp130 J. Biol. Chem., October 16, 1998; 273(42): 27213 - 27219. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hammacher, R. T. Richardson, J. E. Layton, D. K. Smith, L. J. L. Angus, D. J. Hilton, N. A. Nicola, J. Wijdenes, and R. J. Simpson The Immunoglobulin-like Module of gp130 Is Required for Signaling by Interleukin-6, but Not by Leukemia Inhibitory Factor J. Biol. Chem., August 28, 1998; 273(35): 22701 - 22707. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Krebs, H. Griffin, G. Winter, and S. Rose-John Recombinant Human Single Chain Fv Antibodies Recognizing Human Interleukin-6. SPECIFIC TARGETING OF CYTOKINE-SECRETING CELLS J. Biol. Chem., January 30, 1998; 273(5): 2858 - 2865. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Horsten, G. Muller-Newen, C. Gerhartz, A. Wollmer, J. Wijdenes, P. C. Heinrich, and J. Grotzinger Molecular Modeling-guided Mutagenesis of the Extracellular Part of gp130 Leads to the Identification of Contact Sites in the Interleukin-6 (IL-6)·IL-6 receptor·gp130 Complex J. Biol. Chem., September 19, 1997; 272(38): 23748 - 23757. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kalai, F. A. Montero-Julian, J. Grotzinger, V. Fontaine, P. Vandenbussche, R. Deschuyteneer, A. Wollmer, H. Brailly, and J. Content Analysis of the Human Interleukin-6/Human Interleukin-6 Receptor Binding Interface at the Amino Acid Level: Proposed Mechanism of Interaction Blood, February 15, 1997; 89(4): 1319 - 1333. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hammacher, R. J. Simpson, and E. C. Nice The Interleukin-6 (IL-6) Partial Antagonist (Q159E,T162P)IL-6 Interacts with the IL-6 Receptor and gp130 but Fails to Induce a Stable Hexameric Receptor Complex J. Biol. Chem., March 8, 1996; 271(10): 5464 - 5473. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. I. Proudfoot, C. A. Power, A. J. Hoogewerf, M.-O. Montjovent, F. Borlat, R. E. Offord, and T. N. C. Wells Extension of Recombinant Human RANTES by the Retention of the Initiating Methionine Produces a Potent Antagonist J. Biol. Chem., February 2, 1996; 271(5): 2599 - 2603. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Argetsinger, G. W. Hsu, M. G. Myers Jr., N. Billestrup, M. F. White, and C. Carter-Su Growth Hormone, Interferon-[IMAGE], and Leukemia Inhibitory Factor Promoted Tyrosyl Phosphorylation of Insulin Receptor Substrate-1 J. Biol. Chem., June 16, 1995; 270(24): 14685 - 14692. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Panayotatos, E. Radziejewska, A. Acheson, R. Somogyi, A. Thadani, W. A. Hendrickson, and N. Q. McDonald Localization of Functional Receptor Epitopes on the Structure of Ciliary Neurotrophic Factor Indicates a Conserved, Function-related Epitope Topography among Helical Cytokines J. Biol. Chem., June 9, 1995; 270(23): 14007 - 14014. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ehlers, F. D. de Hon, H. K. Bos, U. Horsten, Gün. Kurapkat, H. S. van De Leur, J. Grötzinger, A. Wollmer, J. P. J. Brakenhoff, and S. Rose-John Combining Two Mutations of Human Interleukin-6 That Affect gp130 Activation Results in a Potent Interleukin-6 Receptor Antagonist on Human Myeloma Cells J. Biol. Chem., April 7, 1995; 270(14): 8158 - 8163. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |